See the article here:
Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh